U.S. Supreme Court to Hear Teva Pharmaeutical Industries’ Appeal over Copaxone and Oracle Corp. unveils New MySQL Development Milestone 5.7.4

Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares moved higher after the U.S. Supreme Court today decided that it will hear an appeal filed by the Israel-based pharmaceutical and drug company that develops, produces and markets generic drugs in all treatment categories. Teva is in a patent fight over its bestselling multiple sclerosis drug Copaxone. Copaxone is a branded drug of the company’s that makes up some 20% of its sales and about 50% of profits. This is a move that could see generic manufacturers steer away from introducing cheaper versions onto the market as soon as this